INDV
#1358
Indivior Pharmaceuticals, Inc. - Common Stock
40.2 5 USD
0.00%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
+0.05%
Variación mensual
+4.22%
Variación en los últimos 6 meses
+19.79%
Cambio anual
+19.79%
Cierres anteriores
40.2 3
Open
39.9 8
Mínimo
39.5 8
High
40.9 5
Volumen
69
Financials
- Market Capitalization 4.91 B
- Employee 838
- Founded 2014
- CEO Mark Crossley
- Website www.indivior.com
- Headquarter Delaware, United States
- FIGI BBG01ZTXFLQ6
- Industry Fabricantes de medicamentos — especializados y genéricos
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
15.63
Relación precio/flujo de caja
3.02
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 1142 |  LNTH Lantheus Holdings, Inc. - Common Stock | 102.85 USD | +0.47% | -1.01% | -2.05% | +83.46% | 6.70 B USD | ||
| 1296 |  AMRX Amneal Pharmaceuticals, Inc. - Class A Common Stock | 17.08 USD | +2.34% | +1.43% | +4.79% | +61.90% | 5.45 B USD | ||
| 1772 |  RGC Regencell Bioscience Holdings Limited - Ordinary Shares | 5.25 USD | -7.08% | -17.84% | -69.06% | -63.79% | 2.60 B USD | ||
| 1792 |  SUPN Supernus Pharmaceuticals, Inc. - Common Stock | 46.36 USD | -0.64% | -4.45% | +5.15% | -14.15% | 2.69 B USD |